Results 31 to 40 of about 2,707 (200)
Treatment and economic burden of mucormycosis in China: Case report review and burden estimation
Journal of Clinical Pharmacy and Therapeutics, Volume 47, Issue 7, Page 905-914, July 2022., 2022 The burden estimation of mucormycosis in China shows that drug cost has the highest proportion of total cost (cost/10,000 CNY, type of cost, proportion%). More than 90% of the total cost is direct medical cost, and drug cost is the highest (63.9%) of them followed by inpatient charges during first hospitalization at almost 20%.
Yifei Jian +6 more
wiley +1 more source
Medical Mycology Case Reports, 2017 A 54-year-old woman with acute myeloid leukemia (AML) achieved complete remission by induction chemotherapy, but developed zygomycosis after consolidation therapy.
Testuro Ochi +8 more
doaj +1 more source
Let's talk about sex characteristics—As a risk factor for invasive fungal diseases
Mycoses, Volume 65, Issue 6, Page 599-612, June 2022., 2022 Abstract Biological sex, which comprises differences in host sex hormone homeostasis and immune responses, can have a substantial impact on the epidemiology of infectious diseases. Comprehensive data on sex distributions in invasive fungal diseases (IFDs) are lacking. In this review, we performed a literature search of in vitro/animal studies, clinical
Matthias Egger +4 more
wiley +1 more source
Subcutaneous zygomycosis: A diagnostic and therapeutic challenge
Indian Journal of Paediatric Dermatology, 2022 Subcutaneous zygomycosis is a rare deep fungal infection caused by a group of fungus belonging to the order Entomophtharales. It is a saprophytic fungus and the predominant species causing the infection includes Basidiobolus ranarum and Conidiobolus ...
Ketki Chaudhary +4 more
doaj +1 more source
Managing mucormycosis in diabetic patients: A case report with critical review of the literature
Oral Diseases, Volume 28, Issue 3, Page 568-576, April 2022., 2022 Abstract Background and Purpose Rhino–orbito–cerebral mucormycosis (ROCM) is a rare and potentially fatal invasive fungal infection which usually occurs in diabetic and other immunocompromised patients. This infection is associated with high morbidity and mortality rates.
Fabian M. Beiglboeck +6 more
wiley +1 more source
Muller Journal of Medical Sciences and Research, 2015 Zygomycosis is a serious and often rapidly fatal infection especially in immunocompromised patients. Rhinocerebral mucormycosis is the most common clinical form, accounting for about 50% of the reported cases. Impaired delivery of the antifungal drugs to
Sushil Kumar Aggarwal, Preeti Agarwal
doaj +1 more source
Journal of Infection in Developing Countries, 2020 Introduction: For the best management of the zygomycosis in immunocompromised patients, the present study aims to detect and identify the etiologic agents by DNA sequencing method and their related factors in clinical samples of patients. Methodology:
Parisa Badiee +2 more
doaj +1 more source
Isolated Renal Zygomycosis, A Rare and Lethal Cause of Massive Renal Infarction-Report of Two Cases [PDF]
Journal of Clinical and Diagnostic Research, 2019 Zygomycosis (Mucormycosis) is an infection caused by a class Zygomycetes fungi. The fungal organisms classified as Mucorales order cause a spectrum of predominantly angio-invasive disease in immunosuppressed patients.
Salapathi Shanmugam +3 more
doaj +1 more source
The Pan African Medical Journal, 2016 INTRODUCTION: no comprehensive reports have been published on epidemiological status of Rhinocerebral zygomycosis infections and its outcome in our population, Hence, the current study came to address epidemiological characteristics as well as clinical ...
Vida Bozorgi +5 more
doaj +1 more source
Increasing Incidence of Zygomycosis (Mucormycosis), France, 1997–2006
Emerging Infectious Diseases, 2009 We analyzed hospital records to provide a population-based estimate of zygomycosis incidence and trends over a 10-year period at a national level in France.
Dounia Bitar +7 more
doaj +1 more source